Clinical Trial Update: Lamazym Aftercare Study FR Designed to Provide Treatment for French Patients [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for Lamazym Aftercare in French patients with Alpha-Mannosidosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alpha-mannosidosis

Drugs mentioned

• Lamazym

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: Alpha-Mannosidosis | Phase 3 | Status: COMPLETED